-
IL-7, Human Recombinant: Biology & Use
2026-09-15
IL-7, human recombinant is an exogenous cytokine reagent used to study IL-7 receptor biology, lymphocyte survival, and immune-cell culture responses. Its effects depend on receptor expression, cell state, exposure design, and validated controls; the supplied SARS-CoV-2 protease study does not establish an IL-7 application.
-
4-Ethylphenyl Sulfate: A Matrix-Aware Research Guide
2026-09-15
4-Ethylphenyl sulfate is a microbiota-derived metabolite relevant to renal dysfunction biomarker and gut microbiota-brain interaction research. This guide develops a matrix-aware strategy for separating biological interpretation from adsorption, storage, and assay artifacts.
-
QX77 Workflow for Chaperone-Mediated Autophagy
2026-09-14
QX77 is a molecular chaperone activator for dissecting LAMP2A-dependent autophagy, Rab11-linked trafficking, and embryonic stem cell fate. This workflow connects dose–time optimization with flux-aware controls and a cautious application of recent mitophagy findings.
-
LDH Cytotoxicity Assay Kit: Practical Workflow
2026-09-14
The LDH Cytotoxicity Assay Kit (K2228) provides colorimetric cell cytotoxicity measurement by detecting LDH released from cells with compromised membrane integrity. It is suited to bulk cell damage and viability studies, including cancer research and neurodegenerative disease models, but it should not be used alone to identify a specific cell-death pathway or subcellular mechanism.
-
Kupffer Cell Plasticity in Liver Metastasis
2026-09-13
This study uses complementary lineage-tracing and single-cell approaches to show that liver metastasis-associated macrophages can be maintained through both local macrophage proliferation and infiltration by reprogrammed Kupffer cells when monocyte input is reduced. The findings challenge a simple replacement model and suggest that effective myeloid targeting may need to address monocyte recruitment, macrophage proliferation, and resident-cell plasticity together.
-
STING agonist-1: A Causal Assay Framework
2026-09-12
STING agonist-1 is a small-molecule tool for connecting innate immune activation with B-cell, NF-κB, and tertiary lymphoid structure biology. This article presents a practical assay framework grounded in recent ESCC findings, emphasizing causal controls, compartment-aware readouts, and responsible interpretation.
-
Annexin V-PE Reagent for CAR-T Apoptosis
2026-09-12
This practical guide shows how Annexin V-PE Reagent converts phosphatidylserine exposure into a rapid apoptosis readout for CAR-T cytotoxicity, fratricide, and cell-death studies. It also explains how to combine this assay with structure-guided CD38 binder comparisons without confusing an apoptosis signal with definitive proof of therapeutic mechanism.
-
DeferoxamineB in Ferroptosis Research Workflows
2026-09-11
DeferoxamineB gives oncology researchers a practical way to perturb iron availability while separating ferroptosis from apoptosis, autophagy, and copper-linked cell death. This guide translates the latest ferroptosis/cuproptosis findings into controlled dosing, assay design, and troubleshooting workflows.
-
Cyclosporin A: Mechanism-to-Assay Workflow
2026-09-11
Build more informative immunosuppression assays with Cyclosporin A by pairing calcineurin–NFAT readouts with Cyclophilin A genetic controls. This workflow also separates T-cell effects from mitochondrial permeability transition pore inhibition, improving interpretation in transplantation and autoimmune disease research.
-
Obeticholic Acid: Practical FXR Workflows
2026-09-10
Build receptor-proximal assays for bile acid regulation, cholestasis, and fibrotic liver phenotypes with Obeticholic Acid. This guide connects validated FXR gene readouts with exploratory immune and fibrosis endpoints while emphasizing formulation control and troubleshooting.
-
Fingolimod (FTY720) in T-Cell Engineering
2026-09-10
Fingolimod (FTY720) gives researchers a pharmacological way to test how S1P signaling, lymphocyte trafficking, and neuroprotective pathways shape immune-cell engineering studies. Paired carefully with the magnetic bispecific nano-antibody strategy from the reference study, it can separate systemic cell-distribution effects from local tumor-targeting effects without implying an unvalidated therapeutic combination.
-
Salinomycin Workflows for HCC Drug-Response Assays
2026-09-09
Build more informative hepatocellular carcinoma assays with Salinomycin by separating growth arrest from true cell killing. This workflow combines viability, apoptosis, calcium, transporter, and Wnt/β-catenin readouts to improve mechanistic interpretation and troubleshooting.
-
Nile Red for Lipid Droplet Imaging
2026-09-09
Nile Red converts intracellular lipid storage into a practical fluorescence readout, with red and green channels that help distinguish membrane-associated signal from lipid-droplet enrichment. This workflow connects lipid droplet imaging with oleic acid stress and autophagy experiments while emphasizing assay controls, channel selection, and troubleshooting.
-
Sex Differences in Angiotensin II Hypertension
2026-09-08
Xue, Pamidimukkala, and Hay used telemetry in conscious, freely moving mice to show that chronic angiotensin II produces a substantially larger hypertensive response in males than in females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this divergence to sex hormone-dependent and autonomic mechanisms, providing a rigorous framework for sex-aware cardiovascular research.
-
LDH Cytotoxicity Assay Kit for Nanomaterial Safety
2026-09-08
Use the LDH Cytotoxicity Assay Kit to quantify membrane damage during nanomaterial screening, magnetic hyperthermia studies, and broader cell cytotoxicity measurement. Its non-radioactive workflow pairs well with controls that distinguish intrinsic material toxicity from heat- or treatment-induced injury.